JPMorgan Chase & Co (CMC)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 297.45 |
|---|---|
| 52-week range | 242.45 – 318.00 |
| Return, 1 month / 3 months | +0.7% / −2.1% |
| Return, 1 year / 3 years | +19.5% / +135.0% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 21.8% |
| Worst drawdown (1 year) | -14.3% |
| Average daily value traded | 0.45M EUR |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JPMorgan Chase & Co is a financial services firm based in the United States. It provides consumer banking through branch networks and credit cards, and serves companies and institutions with lending, treasury services, investment banking and markets expertise. It also offers asset and wealth management to individuals and organisations. Its customers include households, small businesses, large corporations and institutional investors across many countries.
JPMorgan Chase & Co trades under the code CMC on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JPMorgan Chase & Co (CMC) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 297.45 on 23 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 70 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 19.5% and over the last three months it fell 2.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 78 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.5% | ||
| From 52-week high | -6.0% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.2% | ||
| 6-month return | 11.9% | ||
| 12-month return, skipping the last month | 18.7% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -14.3% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.45M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.4% |
|---|---|
| 1 month | +0.7% |
| 3 months | −2.1% |
| 6 months | +11.9% |
| 1 year | +19.5% |
| 3 years | +135.0% |
| 5 years | +129.0% |
Signals
| 50-day / 200-day average | 300.75 / 276.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Oct 2026 | USD 1.4677 |
| 6 Jul 2026 | USD 1.3343 |
| 7 Apr 2026 | USD 1.3343 |
| 6 Jan 2026 | USD 1.3343 |
| 6 Oct 2025 | USD 1.3343 |
| 3 Jul 2025 | USD 1.2453 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.